We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SNCA market cap is 15.3M. The company's latest EPS is USD -1.3345 and P/E is -1.14.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 250k | 0 | 0 | 0 |
| Operating Income | -3.85M | -2.53M | -3.61M | -3.78M | -3.15M |
| Net Income | -3.72M | -2.34M | -3.39M | -3.6M | -2.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 15k | 14k | 0 | 0 | 250k |
| Operating Income | -8.63M | -10.69M | -41.85M | -15.72M | -13.07M |
| Net Income | -8.35M | -16.28M | -26.62M | -14.26M | -12.3M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 15.76M | 15.26M | 18.29M | 17.07M | 14.05M |
| Total Liabilities | 3.28M | 1.52M | 2.49M | 2.99M | 2.74M |
| Total Equity | 12.48M | 13.75M | 15.8M | 14.08M | 11.31M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.58M | 13.05M | 12.51M | 15.76M | 14.05M |
| Total Liabilities | 1.46M | 3.28M | 5.15M | 3.28M | 2.74M |
| Total Equity | 5.13M | 9.77M | 7.37M | 12.48M | 11.31M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.36M | -3.53M | -5.73M | -8.39M | -11.13M |
| Investing | -10k | N/A | -4k | -4k | -4k |
| Financing | 15.26M | 4.44M | 9.75M | 11.32M | 11.19M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.26M | -9.03M | -14.77M | -13.36M | -11.13M |
| Investing | N/A | N/A | -54k | -10k | -4k |
| Financing | 6.59M | 14.47M | 24.61M | 15.26M | 11.19M |
| Market Cap | 15.3M |
| Price to Earnings Ratio | -1.14 |
| Price to Sales Ratio | 56.09 |
| Price to Cash Ratio | 1.13 |
| Price to Book Ratio | 1.24 |
| Dividend Yield | - |
| Shares Outstanding | 9.22M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (0.6%) |
| Company Name | Seneca Biopharma Inc |
| Address |
20271 goldenrod lane germantown, maryland 20876 |
| Website | https://senecabio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
